Simultaneous blockade of VEGFR‐1 and VEGFR‐2 activation is necessary to efficiently inhibit experimental melanoma growth and metastasis formation
Jens Gille(Goethe University Frankfurt), Georg Breier(University Hospital Carl Gustav Carus), Regina Heidenreich(Max Planck Society), Reinhard Henschler(German Red Cross), Judith Schmitz(Max Planck Institute for Heart and Lung Research), Daniel J. Hicklin(C4 Therapeutics (United States)), Beatrice Boehme(Goethe University Frankfurt), Andreas Pinter(Goethe University Frankfurt)
Cited by 43
Related Papers
Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele
|Nature|1996|4.2k
Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo
|Nature|1992|2.3k
Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions
|Nature Medicine|2001|1.7k
Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumors
|Cancer Cell|2005|1.6k
Cetuximab-Induced Anaphylaxis and IgE Specific for Galactose-α-1,3-Galactose
|New England Journal of Medicine|2008|1.5k